Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
In the TOGETHER-PsA trial, patients receiving both Zepbound (tirzepatide) and Taltz (ixekizumab) showed a 64% relative improvement in arthritis disease activity compared to those on Taltz alone
Enable cumulative counters in eMAR and duplicate-therapy alerts
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test reveals predispositions in key GLP-1 pathway variants that may help provide context for individual tolerance patterns
When urine becomes more concentrated, minerals can form crystals in the kidneys
US$ 23.12
US$ 25.55
US$ 24.55
US$ 24.89
US$ 24.27
US$ 29.60
